Rubenstein David M.
SEC Form 4 insider trading activity
Rubenstein David M. has filed 4 SEC Form 4 filings (7 transaction rows) across 2 companies, including CG, MRNA, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.
On the most recent filing, Rubenstein David M. is listed as Director at Carlyle Group Inc. Inside the rolling window, Rubenstein David M. reported no open-market purchases and 3 open-market sales totaling $75.8M in CG. The largest disclosed transaction in the window is a sale of 625,000 CG shares on Dec 10, 2025, worth $35.3M.
Companies traded
Other insiders at CG
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$75.8M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rubenstein David M. made?
Rubenstein David M. has filed 4 SEC Form 4 filings (7 transaction rows) across 2 companies, including CG, MRNA since 2025.
Which companies does Rubenstein David M. trade?
Rubenstein David M. has filed SEC Form 4 disclosures for 2 companies, including CG, MRNA.
When was Rubenstein David M.'s most recent SEC Form 4 filing?
Rubenstein David M.'s most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.
What is Rubenstein David M.'s total buy and sell value in the current window?
Inside the rolling retention window, Rubenstein David M. bought $0 and sold $75.8M based on SEC Form 4 filings.
What was Rubenstein David M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 625,000 CG shares on 2025-12-10, worth $35.3M, per SEC Form 4 filings.